The effects of morphine on Parkinson’s-related genes PINK1 and PARK2

Related articles

25 Mar 2020 : Laboratory Research

An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson’s Disease

Yaping Wang, Zhiyun Wang

DOI: 10.12659/MSM.920846

22 Oct 2018 : Animal Research

Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease

Nour Erekat, Muhammed D. Al-Jarrah

DOI: 10.12659/MSM.909032

02 Apr 2017 : Laboratory Research

MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson’s Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways

Ying Liu, Yanfeng Song, [...] Xiaotun Zhu - Show fewer authors

DOI: 10.12659/MSM.900218

02 Jun 2017 : Laboratory Research

Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells

Jinyan Xu, Xiang Gao, [...] Chunying Yang, Li Chen, Zhengjun Chen - Show fewer authors

DOI: 10.12659/MSM.901995

18 Jun 2017 : Laboratory Research

Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson’s Disease Patients: Search for a Disease Indicator

Likun Yang, Changfeng Guo, [...] Jie Zhu, Yi Feng, Weiliang Chen, Zhizhong Feng, Dan Wang, Shibai Sun, Wei Lin, Yuhai Wang - Show fewer authors

DOI: 10.12659/MSM.904240

10 Nov 2017 : Clinical Research

High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson’s Disease Patients

Jinzhi Zhang, Xiao Zhang, [...] Lijuan Wang, Caidi Yang - Show fewer authors

DOI: 10.12659/MSM.904399

01 Aug 2010

Long-term adaptation to high doses of morphine causes desensitization of micro-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits

Lenka Bourova, Miroslava Vosahlikova, [...] Dmytro Kagan, Katerina Dlouha, Jiri Novotny, Petr Svoboda - Show fewer authors

23 Dec 2017 : Clinical Research

High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson’s Disease

Neil A. Kelly, Kimberly H. Wood, [...] Jane B. Allendorfer, Matthew P. Ford, C. Scott Bickel, Jon Marstrander, Amy W. Amara, Thomas Anthony, Marcas M. Bamman, Frank M. Skidmore - Show fewer authors

DOI: 10.12659/MSM.906179

13 May 2016 : Laboratory Research

Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson’s Disease

Peng Shao, Yun-xia Yu, [...] Jing-xi Bao - Show fewer authors

DOI: 10.12659/MSM.895798

28 Nov 2016 : Animal Research

Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain

Shi-Feng Wang, Cheng-Gong Dong, [...] Xue Yang, Jian-Jun Yin - Show fewer authors

DOI: 10.12659/MSM.897702

02 Dec 2016 : Case report

Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy

Raja Mehanna, Joohi Jimenez-Shahed, [...] Ilia Itin - Show fewer authors

DOI: 10.12659/AJCR.900537

01 Aug 2012

Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit

George B. Stefano, Kirk J. Mantione, [...] Milena Králíčková, Radek Ptacek, Hana Kuzelova, Tobias Esch, Richard M. Kream - Show fewer authors

DOI: 10.12659/MSM.883259

01 Feb 2010

Melatonin MT1 and MT2 receptor expression in Parkinson's disease

Nikhil Adi, Deborah C Mash, [...] Yousuf Ali, Carlos Singer, Lina Shehadeh, Spyridon Papapetropoulos - Show fewer authors

01 Jan 2005

Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.

Yu Watanabe, Toshiki Himeda, [...] Tsutomu Araki - Show fewer authors

01 Dec 2004

Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson’s disease

Elisenda Sanz, Manuel Romera, [...] Lydia Belyk, J I Marco, Mercedes Unzeta - Show fewer authors

02 Jul 2004

Botulinum toxin type B for gait freezing in Parkinson’s disease

Hubert H. Fernandez, Margaret C. Lannon, [...] Martha E. Trieschmann, Joseph H. Friedman - Show fewer authors

07 Aug 2002

Immune processes in the pathogenesis of Parkinson’s disease – a potential role for microglia and nitric oxide

Anna Członkowska, Iwona Kurkowska-Jastrzębska, [...] Andrzej Członkowski, Doris Peter, George B. Stefano - Show fewer authors

01 Jan 1970

Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson’s disease?

Hubert H. Fernandez, Joseph H. Friedman, [...] Alan J. Fischman, Richard B. Noto, Margaret C. Lannon - Show fewer authors

01 Sep 1998

Dopaminergic modulation of cognition in Parkinson's disease: the effects of apomorphine

Evzen Ruzicka, Farid El Massioui, [...] Bernard Pillon, Bruno Dubois, Bernard Renault, Yves Agid - Show fewer authors